ArticleHematology, transfusion and cell therapy

Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis.

Selin Küçükyurt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.